Zoekresultaten - Jan Vesterbacka

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection door Anoop T Ambikan, Sara Svensson-Akusjärvi, Shuba Krishnan, Maike Sperk, Piotr Nowak, Jan Vesterbacka, Anders Sönnerborg, Rui Benfeitas, Ujjwal Neogi

Volledige tekst

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers door Jan Vesterbacka, Javier Rivera, Kajsa Noyan, Mariona Parera, Ujjwal Neogi, Malu Calle, Roger Paredes, Anders Sönnerborg, Marc Noguera-Julian, Piotr Nowak

Volledige tekst

Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy. door Jan Vesterbacka, Piotr Nowak, Babilonia Barqasho, Samir Abdurahman, Jessica Nyström, Staffan Nilsson, Hiroyuki Funaoka, Tatsuo Kanda, Lars-Magnus Andersson, Magnus Gisslèn, Anders Sönnerborg

Volledige tekst

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling door Sara Svensson Akusjärvi, Anoop T. Ambikan, Shuba Krishnan, Soham Gupta, Maike Sperk, Ákos Végvári, Flora Mikaeloff, Katie Healy, Jan Vesterbacka, Piotr Nowak, Anders Sönnerborg, Ujjwal Neogi

Volledige tekst

Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV door Aswathy Narayanan, Oscar Kieri, Jan Vesterbacka, Lokeshwaran Manoharan, Puran Chen, Mahin Ghorbani, Hans-Gustaf Ljunggren, Margaret Sällberg Chen, Soo Aleman, Anders Sönnerborg, Shilpa Ray, Piotr Nowak

Volledige tekst

Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals door Sara Svensson Akusjärvi, Shuba Krishnan, Bianca B. Jütte, Anoop T. Ambikan, Soham Gupta, Jimmy Esneider Rodriguez, Ákos Végvári, Maike Sperk, Piotr Nowak, Jan Vesterbacka, J. Peter Svensson, Anders Sönnerborg, Ujjwal Neogi

Volledige tekst

Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV door Shilpa Ray, Aswathy Narayanan, Jan Vesterbacka, Ola Blennow, Puran Chen, Yu Gao, Giorgio Gabarrini, Hans-Gustaf Ljunggren, Marcus Buggert, Lokeshwaran Manoharan, Margaret Sällberg Chen, Soo Aleman, Anders Sönnerborg, Piotr Nowak

Volledige tekst

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDResear... door Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Söderdahl, Anders Österborg, C.I. Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Marcus Buggert, Per Ljungman, Soo Aleman, Hans-Gustaf Ljunggren

Volledige tekst

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine door Caroline Boulouis, Tobias Kammann, Angelica Cuapio, Tiphaine Parrot, Yu Gao, Elli Mouchtaridi, David Wullimann, Joshua Lange, Puran Chen, Mira Akber, Olga Rivera Ballesteros, Jagadeeswara Rao Muvva, COVAXID study group, C. I. Edvard Smith, Jan Vesterbacka, Oscar Kieri, Piotr Nowak, Peter Bergman, Marcus Buggert, Hans-Gustaf Ljunggren, Soo Aleman, Johan K. Sandberg

Volledige tekst

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDResear... door Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Yu Gao, Gunnar Söderdahl, Anders Österborg, C.I.Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Per Ljungman, Marcus Buggert, Soo Aleman, Hans-Gustaf Ljunggren

Volledige tekst

Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial door Jonas Sundén-Cullberg, Puran Chen, Henrike Häbel, Paul Skorup, Helena Janols, Johan Rasmuson, Katarina Niward, Åse Östholm Balkhed, Katerina Chatzidionysiou, Hilmir Asgeirsson, Ola Blennow, Åsa Parke, Anna-Karin Svensson, Jagadeeswara Rao Muvva, Hans-Gustav Ljunggren, Anna-Carin Horne, Ulrika Ådén, Jan-Inge Henter, Anders Sönnerborg, Jan Vesterbacka, Piotr Nowak, Jon Lampa

Volledige tekst

Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial. door Jonas Sundén-Cullberg, Puran Chen, Henrike Häbel, Paul Skorup, Helena Janols, Johan Rasmuson, Katarina Niward, Åse Östholm Balkhed, Katerina Chatzidionysiou, Hilmir Asgeirsson, Ola Blennow, Åsa Parke, Anna-Karin Svensson, Jagadeeswara Rao Muvva, Hans-Gustav Ljunggren, Karolinska KI/K COVID-19 Treatment Working Group, Anna-Carin Horne, Ulrika Ådén, Jan-Inge Henter, Anders Sönnerborg, Jan Vesterbacka, Piotr Nowak, Jon Lampa

Volledige tekst

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial door Peter Bergman, MD, Ola Blennow, MD, Lotta Hansson, MD, Stephan Mielke, MD, Piotr Nowak, MD, Puran Chen, MD, Gunnar Söderdahl, MD, Anders Österborg, MD, C. I. Edvard Smith, MD, David Wullimann, MSc, Jan Vesterbacka, MD, Gustaf Lindgren, MD, Lisa Blixt, MD, Gustav Friman, MD, Emilie Wahren-Borgström, MD, Anna Nordlander, MD, Angelica Cuapio Gomez, MD, Mira Akber, MSc, Davide Valentini, MD, Anna-Carin Norlin, MD, Anders Thalme, MD, Gordana Bogdanovic, MD, Sandra Muschiol, PhD, Peter Nilsson, PhD, Sophia Hober, PhD, Karin Loré, PhD, Margaret Sällberg Chen, PhD, Marcus Buggert, PhD, Hans-Gustaf Ljunggren, MD, Per Ljungman, MD, Soo Aleman, MD

Volledige tekst